All Stories

  1. Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, September 2019, Taylor & Francis

    Marcell Csanádi, Andras Harsanyi